Newly Released OpenClinica 3.1 Will be Demonstrated at the Drug Information Association Annual Meeting
“OpenClinica 3.1 is the most capable, easy to use, and flexible release to date,” said Cal Collins, OpenClinica’s CEO. “The software improves the efficiency of data managers, monitors, and site users to capture and clean data, provides a way to easily customize data extract formats, includes an expanded web services interface to facilitate interoperability with other systems and data sources, and supports dynamic skip logic in case report forms. Both the Enterprise and Community editions of the software have been heavily tested at OpenClinica and by beta users in the open source community over the past six months, and we are pleased to release the technology for general production use.”
OpenClinica will hold demonstrations of the new software and answer questions at the
Sound technology and a model that makes it easy to both adopt and adapt has propelled the growth of OpenClinica. Earlier this month, the company released statistics showing that over the last year, the number of clinical trials powered by OpenClinica grew by 250 percent. Collins says there are over 400 active production implementations worldwide and a single implementation can support multiple trials.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Everything to Know About FDA’s Push Towards Radical Transparency in 2025
September 17th 2025
- IQVIA and Veeva Join Forces to Improve Efficiency and Patient Outcomes
September 17th 2025
- Managing Background Therapies in the NIMBLE Phase III Trial
September 17th 2025
- Generative AI Transforms Clinical Study Report Development
September 16th 2025